Growth Metrics

West Pharmaceutical Services (WST) Cash from Operations (2016 - 2026)

West Pharmaceutical Services has reported Cash from Operations over the past 18 years, most recently at 89900000.0 for Q1 2026.

  • Quarterly Cash from Operations fell 30.53% to 89900000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 715300000.0 through Mar 2026, up 7.63% year-over-year, with the annual reading at 754800000.0 for FY2025, 15.52% up from the prior year.
  • Cash from Operations was 89900000.0 for Q1 2026 at West Pharmaceutical Services, down from 251100000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 251100000.0 in Q4 2025 and troughed at 89900000.0 in Q1 2026.
  • The 5-year median for Cash from Operations is 173100000.0 (2022), against an average of 176388235.29.
  • Biggest five-year swings in Cash from Operations: skyrocketed 70.46% in 2022 and later crashed 30.53% in 2026.
  • Tracing WST's Cash from Operations over 5 years: stood at 230800000.0 in 2022, then grew by 3.6% to 239100000.0 in 2023, then decreased by 20.49% to 190100000.0 in 2024, then soared by 32.09% to 251100000.0 in 2025, then crashed by 64.2% to 89900000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 89900000.0, 251100000.0, and 197200000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.